1994-11--1996-12 Postdoctoral: Massachusetts Institute of Technology
1991-01--1994-10 PhD: University of Texas Southwestern Medical Center
1985-09--1988-12 Master's: Tsinghua University
1980-09--1985-07 Bachelor's: Tsinghua University
2019-09~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Selected Talent of Shanghai
2013-04~2022-12 - Key Laboratory of Receptor Structure and Function, Chinese Academy of Sciences - Founder, Director
2010-07~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Director of the Center for Drug Target Structure and Function
2010-01~2010-07 - Van Andel Research Institute, USA - Director of the Center for Structural Science and Drug Discovery
2007-03~2009-12 - Van Andel Research Institute, USA - Distinguished PI/Professor
2002-08~2007-03 - Van Andel Research Institute, USA - Senior PI/Professor
2001-08~2002-07 - Glaxo Wellcome Research Institute, USA - Senior Researcher
1999-08~2001-07 - Glaxo Wellcome Research Institute, USA - Associate Researcher
1996-12~1999-07 - Glaxo Wellcome Research Institute, USA - Researcher
1994-11~1996-12 - Massachusetts Institute of Technology, USA - Postdoctoral
1994-11~1996-12 - Massachusetts Institute of Technology, USA - Research Assistant
1991-01~1994-10 - University of Texas Southwestern Medical Center, USA - PhD
1985-09~1988-12 - Tsinghua University, China - Master's
1980-09~1985-07 - Tsinghua University, China - Bachelor's
2024: 'Revealing the molecular mechanism of GPCR kinase recognition and regulation of GPCR biased signal transduction' selected as one of the 'Top Ten Advances in Scientific Innovation' (Basic Research Category) by the Shanghai Branch of the Chinese Academy of Sciences
2023: 'Pearl Leading Talent of Pudong New Area'
2023: 'Elucidating the structure and function of multiple drug targets' selected as one of the 'Top Ten Advances in Scientific Innovation' (Basic Research Category) by the Shanghai Branch of the Chinese Academy of Sciences
2022: 'Magnolia Honor Award' by Shanghai
2022: 'First Prize of the Ninth 'Contribution Award' by the Chinese Federation of Returned Overseas Chinese
2022: 'Excellent Mentor Award' by the Chinese Academy of Sciences
2022: 'Twenty-second Wu Jieping-Paul Janssen Medical and Pharmaceutical Award'
2021: 'Excellent Mentor Award' by the Chinese Academy of Sciences
2021: 'Thirteenth Tan Jiazhen Life Science Achievement Award'
2020: 'Magnolia Memorial Award' by Shanghai
2020: 'Providing structural theoretical basis for new drug development by analyzing protein structure' selected as one of the 'Major Advances in Chinese Medicine' (Pharmacy Department) by the Chinese Academy of Medical Sciences
2019: 'Excellent Mentor Award' by the Chinese Academy of Sciences
2016: 'WuXi AppTec Life Chemistry Outstanding Achievement Award'
2016: 'Hans Neurath Award' by the International Protein Society
2015: 'Overcoming major scientific problems in cell signal transduction' selected as one of the 'Top Ten Scientific Advances' by the Chinese Academy of Sciences
2014: 'Elucidating the signal pathway of strigolactone regulating rice tillering and plant type' selected as one of the 'Top Ten Scientific Advances in China'
2001: 'GSK Outstanding Research Award'
1999: 'GSK Distinguished Research Award'
Research
Structural Biology Biophysics
Molecular recognition of itch-associated neuropeptides by bombesin receptors, Huaqiang Xu, 2023
Structure basis for inhibition of SARS-CoV-2 by the feline drug GC376, Huaqiang Xu, 2023
AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors, Huaqiang Xu, 2023
Structures of the entire human opioid receptor family, Huaqiang Xu, 2023
GPCR activation and GRK2 assembly by a biased intracellular agonist, Huaqiang Xu, 2023
Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2, Huaqiang Xu, 2022
Structural insights into the ligand binding and G(i) coupling of serotonin receptor 5-HT5A, Huaqiang Xu, 2022
Structural basis for the tethered peptide activation of adhesion GPCRs, Huaqiang Xu, 2022
Hormone- and antibody-mediated activation of the thyrotropin receptor, Huaqiang Xu, 2022
Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1, Huaqiang Xu, 2022
Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19, Huaqiang Xu, 2022
Structure insights into selective coupling of G protein subtypes by a class B G protein-coupled receptor, Huaqiang Xu, 2022
Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody, Huaqiang Xu, 2022
Structural insights into ligand binding and activation of the human thyrotropin-releasing hormone receptor, Huaqiang Xu
